SIC
JANX icon

SJS Investment Consulting’s Janux Therapeutics JANX Stock Holding History

SJS Investment Consulting’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$292 Buy
+19
New +$275 ﹤0.01% 2404

Other funds holding JANX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

SJS Investment Consulting's JANX Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Janux Therapeutics (JANX) in Q2 2026: 19 shares worth $292. The stake represents ﹤0.01% of the portfolio and ranks #2404 among its holdings.

27 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • SJS Investment Consulting held 19 shares of Janux Therapeutics worth $292 as of Q2 2026.
  • Janux Therapeutics was a new SJS Investment Consulting position in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2404 holding.
  • 27 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.